Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-05-07 @ 9:10 PM
Study NCT ID:
NCT02743351
Status:
COMPLETED
Last Update Posted:
2023-02-08
First Post:
2016-02-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
Sponsor:
Fate Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Cell Transplants | View |
| None | Hematopoietic Cell Transplant | View |
| None | HCT | View |
| None | Hematologic Malignancies | View |
| None | Hematologic Malignancy | View |
| None | Acute Myeloid Leukemia | View |
| None | Acute Lymphoblastic Leukemia | View |
| None | ALL | View |
| None | AML | View |
| None | Myelodysplastic Syndrome | View |
| None | MDS | View |
| None | Allogeneic | View |
| None | CML | View |
| None | Stem Cell Transplant | View |
| None | Transplant | View |
| None | aGvHD | View |
| None | Acute graft-versus-host Disease | View |
| None | cGvHD | View |
| None | Chronic graft-versus-host Disease | View |